Blickenstaff Kim D's Form 4 filing

Tandem Diabetes Care Inc (TNDM) · filed Nov 22, 2024

Accession no.: 0001438133-24-000217
Filed: Nov 22, 2024
Trade date: Nov 20-21, 2024
Filing delay: 2 days
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market sales total $1.24M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Blickenstaff Kim DCIK 0001238913	Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Nov 20, 2024	Common Stock	SSaleDisposed	−10,000	$30.00^F1	−$300,000	195,190	Indirect
Nov 21, 2024	Common Stock	SSaleDisposed	−30,000	$31.38^F3	−$941,400	165,190	Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $30.00 to $30.01

Referenced by the price of 1 transaction in Table I.

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $31.22 to $31.63.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)